About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg Impact Factor
h-index
g-index
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Tufts Center for the Study of Drug Development
›
Top Articles
Tufts Center for the Study of Drug Development
United States of America
(csdd.tufts.edu)
241
(top 24%)
articles
11.7K
(top 15%)
citations
53
(top 21%)
★★
articles
8
(top 10%)
★★★
articles
2.7
(top 17%)
Avg IF
40
(top 18%)
H-Index
106
(top 12%)
G-Index
76
journals
Most Cited Articles of Tufts Center for the Study of Drug Development in 2015
Title
Journal
Year
Citations
The cost of drug development
New England Journal of Medicine
2015
73
The roles of patents and research and development incentives in biopharmaceutical innovation
Health Affairs
2015
36
Complementary versus companion diagnostics: apples and oranges?
Biomarkers in Medicine
2015
30
The evolution of biotechnology and its impact on health care
Health Affairs
2015
26
Quantifying the magnitude and cost of collecting extraneous protocol data
American Journal of Therapeutics
2015
19
A Tool for Predicting Regulatory Approval After Phase II Testing of New Oncology Compounds
Clinical Pharmacology and Therapeutics
2015
17
Market watch: Where is personalized medicine in industry heading?
Nature Reviews Drug Discovery
2015
16
Establishing Return-on-Investment Expectations for Patient-Centric Initiatives
Therapeutic Innovation and Regulatory Science
2015
13
Regulatory Definitions and Good Pharmacovigilance Practices in Social Media: Challenges and Recommendations
Therapeutic Innovation and Regulatory Science
2015
8
Can genomic medicine improve financial sustainability of health systems?
Molecular Diagnosis and Therapy
2015
8
An Examination of eClinical Technology Usage and CDISC Standards Adoption
Therapeutic Innovation and Regulatory Science
2015
7
Impact of Postapproval Evidence Generation on the Biopharmaceutical Industry
Clinical Therapeutics
2015
5
site/software ©
exaly
; All materials licenced under
CC by-SA
.